Starting oral risdiplam soon after birth may put babies with spinal muscular atrophy on the path to normal development, new ...

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending ...

Biogen’s second quarter delivered results that exceeded Wall Street’s revenue and profit expectations, a performance that was ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $165.9, a high estimate of $219.00, and a low estimate of $115.00. This current ...

Biogen CEO Chris Viehbacher says Novo Nordisk's Alzheimer's trial success could lead to combination therapies, boosting ...

Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

Biogen beat Q2 estimates with cost control and new launches, but MS declines and pipeline risks cloud growth. Find out why ...

Biogen (($CC:HTER)) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) is conducting a significant ...

A special species of ant might hold the secret to effective teamwork. Researchers report that, as weaver ants ( Oecophylla ...

Eli Lilly & Biogen's Alzheimer's drugs may offer minimal impact despite aggressive marketing. Click here to get insights on ...

The dilemma around the cost of health care has loomed over a fierce Beacon Hill debate about the commission’s makeup.

Biogen (($CC:HTER)) announced an update on their ongoing clinical study. Biogen Inc. has initiated a Phase 3 clinical trial ...